Vaseline

Manufacturer
Conopco Inc. d/b/a Unilever | Alberto-Culver USA Inc.
Effective date
2012-10-02
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 22:33:12

Label at a glance#

ProductVaseline Lip Therapy Advanced Formula
Active ingredientpetrolatum
Label structure9 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient
WHITE PETROLATUM, USP (100%)

OTC - PURPOSE SECTION

Purpose:
Skin Protectant

INDICATIONS & USAGE SECTION

Uses
▪
  temporarily protects and helps relieve chapped or cracked skin and lips
▪  helps protect from the drying effects of wind and cold weather

WARNINGS SECTION

Warnings:
For External Use Only

OTC - WHEN USING SECTION

When using this product do not get into eyes

OTC - ASK DOCTOR SECTION

See a doctor if condition lasts more than 7 days

OTC - DO NOT USE SECTION

Do not use on ▪deep or puncture wounds  ▪animal bites  ▪serious burns

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.  If swallowed get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Directions apply as needed

INACTIVE INGREDIENT SECTION

Inactive Ingredient  Flavor

OTC - QUESTIONS SECTION

Questions?  Call 1-800-457-7084

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

VLT 0.35 oz. PDPVaseline Lip Therapy Advanced 0.35 oz PDPVaseline Lip Therapy Advanced 0.35 oz PDP

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

VLT blister cardVaseline Lip Therapy Advanced 0.35 oz blister cardVaseline Lip Therapy Advanced 0.35 oz blister card

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
204754petrolatum 100 % Topical JellyPSN3
210871Vaseline 100 % Topical OintmentPSN3
210871petrolatum 1 MG/MG Topical Ointment [Vaseline]SBD3
204754petrolatum 1 MG/MG Topical OintmentSCD3
204754petrolatum 100 % Topical JellySY3
210871Vaseline 1 MG/MG Topical OintmentSY3
210871Vaseline 100 % Topical OintmentSY3

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
64942-0053-22020-01-31C16284748780-19d75b9d0-5b54-f424-e053-dadaa90a57ceVaseline Lip Therapy Advanced Formula

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
64942-0053-1VaselineLip Therapy Advanced Formula10 g in 1 TUBEOINTMENT103
64942-0053-2VaselineLip Therapy Advanced Formula1 in 1 BLISTER PACKOINTMENT13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
64942-0053VASELINE LIP THERAPY ADVANCED FORMULA (PETROLATUM) OINTMENT [CONOPCO INC. D/B/A UNILEVER]3Legacy NDC, 2 package rows20121005_c4e87f3a-5e3b-4c9b-a1cd-21e9b3b625e3.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
petrolatumACTIVE INGREDIENT4T6H12BN9U3
petrolatumACTIVE MOIETY4T6H12BN9U3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
64942-005364942-0053-1, 64942-0053-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
NameUNIIKind
petrolatum4T6H12BN9UACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
c22f300e-1305-4642-8472-087d5c67fc21c4e87f3a-5e3b-4c9b-a1cd-21e9b3b625e32012-10-02WarningsExact identifier
spl id: c22f300e-1305-4642-8472-087d5c67fc21
spl set id: c4e87f3a-5e3b-4c9b-a1cd-21e9b3b625e3

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.